Table 2 Duration of hospitalization between groups.

From: Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial

 

Data distribution

Time (days)

NAM

75% (IC95%)

12.0 (7.0–21.0)

50% (IC95%)

7.0 (4.0–10.0)

25% (IC95%)

4.0 (3.0–5.0)

Mean (SD)

8.9 (1.4)

AM

75% (IC95%)

5.0 (4.0–17.0)

50% (IC95%)

4.0 (2.0–5.0)

25% (IC95%)

2.5 (1.0–3.0)

Mean (SD)

5.10 (1.19)

  1. Hazard ratio = 2.16 (IC 95%: 1.07–4.34), p = 0.0314.
  2. AM Active Mouthwash, NAM Non-Active Mouthwash groups, SD Standard deviation.
Back to article page